Olive Medical unveils cost effective surgical imaging system
3 February 2012

US-based medical device company, Olive Medical, has launched the industry's first surgical camera system to enable surgical imaging at a lower cost.

 
Boston implants first patient with Promus Element stent
3 February 2012

Boston Scientific has announced the first European patient implant of its Promus Element Plus Stent System at the Columbus and San Raffaele Hospitals in Milan, Italy.

 
AngioDynamics to take over Navilyst Medical
2 February 2012

AngioDynamics, a medical device provider, has signed a definitive agreement to acquire global medical device company Navilyst Medical from Avista Capital Partners for around $372m.

 
FDA clears Roche CT/NG screening assay
2 February 2012

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Roche Molecular Diagnostics' cobas CT/NG test, used to detect chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patient…

 
Endologix enrols first patient in Ventana device trial
1 February 2012

Endologix, a developer and marketer of innovative treatments for aortic disorders, has enrolled the first patient in the company's US clinical trial to evaluate the Ventana fenestrated stent graft system for the endovascular repair of juxtarenal and …

 
CardioKinetix Parachute implant gets extended European approval
1 February 2012

The European commission has granted extended CE Mark approval for two additional sizes of CardioKinetix's Parachute ventricular partitioning device, used to treat patients with heart failure resulting from a heart attack.

 
Gamma Therapeutics, Zeus Scientific partner to develop ELISA kits
31 January 2012

US-based early stage biotechnology venture Gamma Therapeutics has signed a manufacturing contract with Zeus Scientific, a manufacturer of autoimmune and infectious disease immunoassay kits and products for the clinical diagnostic industry.

 
Global mobile health applications market to nearly double in 2012
31 January 2012

The global smartphone application market for mobile healthcare is expected to reach $1.3bn in 2012, up from $718m in 2011, according to a report.

 
US researchers develop new brain tumour diagnostic test
30 January 2012

Researchers at the UT Southwestern Medical Center, US, have developed a new imaging technique to diagnose brain tumours, avoiding the need for surgery in patients whose tumours are located in areas of the brain where performing a biopsy is dangerous.

 
Accuray reports benefits of CyberKnife robotic radiosurgery system
30 January 2012

Accuray has announced the results of a study demonstrating the benefits of the CyberKnife robotic radiosurgery system in treating central lung tumours using stereotactic body radiotherapy (SBRT).

 
DiagnoCure announces colorectal cancer assay results
27 January 2012

DiagnoCure has announced that its partner for the Previstage GCC colorectal cancer staging test Signal Genetics has reported the results of a new study at the 2012 American Society of Clinical Oncology Gastrointestinal Cancer Symposium held in San Fr…

 
FDA clears Interventional Spine intervertebral body fusion device
27 January 2012

The US Food and Drug Administration has approved Interventional Spine's Opticage expandable intervertebral body fusion device, used for the treatment of degenerative disc disease (DDD).

 
Boston IVF develops new saliva test to monitor infertility treatment
26 January 2012

Boston IVF, a medical practice centre providing specialised infertility treatment, has introduced the first needle-free saliva test that will replace the daily blood tests required to monitor infertility treatment.

 
Medtronic enrols first patient in Arctic Front cardiac system comparison trial
26 January 2012

Medtronic has enrolled its first patient in the Fire and Ice clinical trial, which is designed to compare the long-term safety, effectiveness and ease of use of the Medtronic Arctic Front cardiac cryoablation system with the Biosense Webster CARTO sy…

 
Alere wins FDA CLIA waiver for rapid flu test
25 January 2012

Alere has received a clinical laboratory improvement amendments (CLIA) waiver from the US Food and Drug Administration (FDA) for its influenza A&B test.

 

Questions? Tel: 0121 616 5051